Data through FY2026 Q3 (Jun 30, 2026)
UCB BioSciences Inc.
Company profile for UCB BioSciences Inc. covers 16 filings across the reporting window. FY2026 certified median offer: $106,870.
- FY2026 certified median
- $106,870
- Total filings
- 16
- FY2026 25th–75th percentile
- $95,402–$114,660
- Top job title
- DMPK Lead
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 3 | $200,300 | $148,400 | $200,300 |
| FY2025 | 6 | $142,717 | $99,082 | $147,341 |
| FY2026 (Q1–Q3) | 7 | $106,870 | $95,402 | $114,660 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- DMPK Lead2 filings
- Head US Tox & GTx Tox Strategy Lead2 filings
- Project Lead Statistician2 filings
- Scientist II2 filings
- Associate Scientist1 filings
- Benefit Risk Excellence Lead1 filings
- Digital Transformation Lead Transvers. Delivery & US ES SPOC1 filings
- Scientist I1 filings
- Senior Research Associate1 filings
- Senior Scientist I Discovery Chemistry US1 filings
Top cities
- Cambridge12 filings
- Morrisville2 filings
- Smyrna1 filings
- Raleigh1 filings